viernes, 16 de junio de 2017

La medicina Genetica una opción para la enfermedad de Huntington Junio 2017

Huntington's Disease News Weekly Digest

Si te interesa saber mas sobre nutrigenomica... llama 55 1247 3830

 

Contents:


Cell Transport ‘Traffic Jam’ Caused by Mutated Protein, Researchers Discover

Jun 08, 2017 02:56 pm | Alice Melão

 

 

mutated huntingtin proteinA mutated form of the huntingtin (mHTT) protein has been acknowledged as the cause of Huntington’s disease, but researchers have not been fully clear about how it disrupts the function of brain cells. A study, “Mutant Huntingtin Disrupts the Nuclear Pore Complex,” that was published in the scientific journal Neuron provides new knowledge that can help […]
The post Cell Transport ‘Traffic Jam’ Caused by Mutated Protein, Researchers Discover appeared first on Huntington's Disease News.
Read More
share on TwitterLike Cell Transport ‘Traffic Jam’ Caused by Mutated Protein, Researchers Discover on Facebook


Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials

Jun 06, 2017 01:49 pm | Magdalena Kegel

 

Voyager gene therapy candidateVoyager Therapeutics has a new candidate for the treatment of Huntington’s disease. The selected gene therapy is called VY-HTT01 and aims to prevent the production of protein from the mutant huntingtin gene (HTT). The compound is now undergoing preclinical studies of drug characteristics and toxicology as the company plans to file an investigational new drug (IND) application […]
The post Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials appeared first on Huntington's Disease News.
Read More
share on TwitterLike Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials on Facebook

Recent Posts

Researchers Identify a Key Link Between the Brain’s Immune Cells and Neurodegenerative Disorders
Researchers Find Common Disease Processes in Huntington’s, Alzheimer’s and Parkinson’s
Neuroprotective Pathway May Be Key to Understanding Huntington’s Progression
University of Sussex Researchers Receive $3.37 Million to Develop Huntington’s Treatments
Researchers Discover Why Defects Form in Blood Brain Barrier of Huntington’s Patients
Fundación Verónica Ruiz
Enfermedades Neurodegenerativas y Enfermedad de Huntington México Diagnostico no es Destino

No hay comentarios:

Publicar un comentario